抗A型塞内卡病毒天然产物筛选及颉颃作用机制研究

doi:10.16431/j.cnki.1671-7236.2023.02.031

中国畜牧兽医 ›› 2023, Vol. 50 ›› Issue (2): 734-744.doi: 10.16431/j.cnki.1671-7236.2023.02.031

抗A型塞内卡病毒天然产物筛选及颉颃作用机制研究

蒙英雯^1,2, 李月华², 沙洲^2,3, 李晨钰^2,4, 巩有权^2,5, 董雅琴^2,3, 魏荣^2,3, 邹丰才¹, 尼博^2,3

1. 云南农业大学动物医学院, 昆明 650201;
2. 中国动物卫生与流行病学中心, 青岛 266032;
3. 农业农村部动物生物安全风险预警及防控重点实验室(南方), 青岛 266032;
4. 山西农业大学动物医学学院, 太谷 030800;
5. 黑龙江八一农垦大学动物科技学院, 大庆 163711

收稿日期:2022-09-13 出版日期:2023-02-05 发布日期:2023-02-06
通讯作者: 邹丰才, 尼博 E-mail:zfc1207@vip.163.com;nibo@cahec.cn
作者简介:蒙英雯,E-mail:1187264870@qq.com
基金资助:
中国动物卫生与流行病学中心创新基金(DW2021009);"十四五"国家重点研发计划(2021YFD180030)

Screening of the Natural Products Against Senecavirus A and Study on Its Mechanism of Antagonism

MENG Yingwen^1,2, LI Yuehua², SHA Zhou^2,3, LI Chenyu^2,4, GONG Youquan^2,5, DONG Yaqin^2,3, WEI Rong^2,3, ZOU Fengcai¹, NI Bo^2,3

1. College of Veterinary Medicine, Yunnan Agricultural University, Kunming 650201, China;
2. China Animal Health and Epidemiology Center, Qingdao 266032, China;
3. Key Laboratory of Animal Biosafety Risk Prevention and Control (South), Ministry of Agriculture and Rural Affairs, Qingdao 266032, China;
4. College of Veterinary Medicine, Shanxi Agricultural University, Taigu 030800, China;
5. College of Animal Science and Technology, Heilongjiang Bayi Agricultural University, Daqing 163711, China

Received:2022-09-13 Online:2023-02-05 Published:2023-02-06

摘要/Abstract

摘要： 【目的】从天然产物库中筛选具有颉颃A型塞内卡病毒(Senecavirus A,SVA)活性的天然产物并研究其颉颃作用机制。【方法】利用荧光素酶重组塞内卡病毒(rSVA-NLuc)与BHK-21细胞,结合荧光素酶高通量筛选技术,建立抗SVA药物体外筛选平台。从天然产物库中筛选浓度为10 μmol/L时具有抑制荧光素酶活性效应的天然产物,并进一步利用实时荧光定量RT-PCR验证其抑制活性,通过细胞毒性试验确定其最大无毒浓度。选择病毒感染周期的吸附、入胞、复制、组装释放4个主要过程,利用实时荧光定量RT-PCR、50%组织细胞感染量(TCID₅₀)测定等进行天然产物分子颉颃机制研究。【结果】从包含560种天然产物的分子库中筛选出16种候选抗SVA活性分子,通过实时荧光定量RT-PCR及细胞毒性检测,鉴定出4种安全、有效的天然产物,分别为20S-原人参三醇((20S)-protopanaxatriol)、蕈青霉素(paxilline)、方胆碱(fangchinoline)、竹红菌乙素(hypocrellin B)。作用机制研究显示,20S-原人参三醇能抑制SVA感染过程中的吸附、复制阶段;蕈青霉素在SVA的吸附、入胞、复制、组装释放阶段即整个病毒感染周期均发挥抑制作用;方胆碱能抑制SVA的入胞、复制;竹红菌乙素能抑制SVA的吸附、入胞、复制及组装释放阶段。【结论】本试验从天然产物库中筛选出了4种具有抗SVA活性的天然产物,这些化合物抗病毒效果良好,且作用机制各有不同。本研究为抗SVA药物的进一步研发提供重要参考。

关键词: A型塞内卡病毒(SVA); 天然产物; 高通量筛选; 颉颃机制

Abstract: 【Objective】 The purpose of this study was to screen the natural products with anti-SVA activity from natural products library and to discover the mechanism of their antagonism.【Method】 Incorporating the use of the luciferase report technology,the high throughput platform for in vitro screening of anti-SVA natural products was established.In this platform,recombinant Luciferase reporter virus (rSVA-NLuc) system and BHK-21 cell were used to rapidly screen natural products against SVA from natural products library.The natural products with inhibitory effect on luciferase activity at the concentration of 10 μmol/L were screened from the natural product library,and their inhibitory activity was further verified by quantitative Real-time RT-PCR,at the same time,maximal nontoxic concentrations were determined by cytotoxicity test.The anti-viral mechanisms,which covering 4 main processes of the virus infection cycle including adsorption,entry,replication,assembly and release,were further studied with quantitative Real-time RT-PCR and 50% tissue culture infective dose(TCID₅₀).【Result】 16 natural products against SVA were screened from a library containing 560 natural products.Four safe and effective molecules were identified by quantitative Real-time RT-PCR and cytotoxicity test,namely (20S)-protopanaxatriol,paxilline,fangchinoline and hypocrellin B.Among them,(20S)-protopanaxatriol could inhibit the adsorption,replication of SVA.Paxilline could inhibit the adsorption,entry,replication,assembly and release of SVA.Fangchinoline mainly inhibited the entry and replication of SVA.Hypocrellin B could inhibit the adsorption,entry,replication,assembly and release of SVA.【Conclusion】 A total of 4 natural products against SVA were screened out from the natural products library.These compounds had good antiviral activity and different anti-viral mechanism.This study provided an important reference for the further development of anti SVA drugs.

Key words: Seneca virus A (SVA); natural product; high-throughput screening; antagonism mechanism

中图分类号:

S853.74

蒙英雯, 李月华, 沙洲, 李晨钰, 巩有权, 董雅琴, 魏荣, 邹丰才, 尼博. 抗A型塞内卡病毒天然产物筛选及颉颃作用机制研究[J]. 中国畜牧兽医, 2023, 50(2): 734-744.

MENG Yingwen, LI Yuehua, SHA Zhou, LI Chenyu, GONG Youquan, DONG Yaqin, WEI Rong, ZOU Fengcai, NI Bo. Screening of the Natural Products Against Senecavirus A and Study on Its Mechanism of Antagonism[J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(2): 734-744.

参考文献

[1] ZHANG X,ZHU Z,YANG F,et al.Review of Seneca Valley virus:A call for increased surveillance and research[J]. Frontiers in Microbiology,2018,9:940.
[2] HOUSTUN E,TEMEEYASEN G,PIEYRO P E.Comprehensive review on immunopathogenesis,diagnostic and epidemiology of Senecavirus A[J]. Virus Research,2020,286:198038.
[3] 赵振翔,朱紫祥,杨帆,等.猪塞尼卡谷病毒流行态势与诊断防控研究进展[J].微生物学通报,2017,44(12):3024-3030. ZHAO Z X,ZHU Z X,YANG F,et al.Advance in Seneca Valley virus epidemiology,diagnosis and control[J]. Microbiology China,2017,44(12):3024-3030.(in Chinese)
[4] WU Q,ZHAO X,BAI Y,et al.The first identification and complete genome of Senecavirus A affecting pig with idiopathic vesicular disease in China[J]. Transboundary & Emerging Diseases,2017,64(5):1633-1640.
[5] 高春柳,董雅琴,周晓翠,等.2019年我国部分省份猪群塞内卡病毒流行病学调查[J].黑龙江畜牧兽医,2021,9:99-103. GAO C L,DONG Y Q,ZHOU X C,et al.Epidemiological investigation of Senecavirus A in pig herds in some provinces of China in 2019[J]. Heilongjiang Animal Science and Veterinary Medicine,2021,9:99-103.(in Chinese)
[6] 王迁迁,于永乐,李月华,等.A型塞尼卡病毒检测方法及疫苗研究进展[J].中国畜牧兽医,2022,49(6):2336-2346. WANG Q Q,YU Y L,LI Y H,et al.Advance in detection methods and vaccines of Senecavirus A[J]. China Animal Husbandry & Veterinary Medicine,2022,49(6):2336-2346.(in Chinese)
[7] 杜文琪,夏立叶,李桂梅,等.A型塞内卡病毒VP1蛋白的原核表达及纯化[J].中国畜牧兽医,2022,49(7):2708-2715. DU W Q,XIA L Y,LI G M,et al.Prokaryotic expression and purification of Seneca virus A VP1 protein[J]. China Animal Husbandry & Veterinary Medicine,2022,49(7):2708-2715.(in Chinese)
[8] 莫红芳,揭凯,陈鑫,等.猪塞尼卡谷病毒单克隆抗体的制备及鉴定[J].中国畜牧兽医,2022,49(1):307-317. MO H F,JIE K,CHEN X,et al.Preparation and identification of monoclonal antibodies against porcine Seneca Valley virus[J]. China Animal Husbandry & Veterinary Medicine,2022,49(1):307-317.(in Chinese)
[9] 张永宁,张舟,诸明欣,等.A型塞内卡病毒VP2蛋白原核表达及其多克隆抗体的制备[J].中国畜牧兽医,2019,46(1):256-263. ZHANG Y N,ZHANG Z,ZHU M X,et al.Prokaryotic expression of the VP2 protein of Senecavirus A and preparation of its polyclonal antibodies[J]. China Animal Husbandry & Veterinary Medicine,2019,49(1):256-263.(in Chinese)
[10] DONG J,RAO D,HE S,et al.Emergence of a novel recombinant USA/GBI29/2015-like strain of Seneca Valley virus in Guangdong province,2018[J]. Canadian Journal of Veterinary Research,2021,85(3):224-228.
[11] LIU J,GUO Q,LI H,et al.Genomic diversity and recombination of Seneca Valley viruses emerged in pig herds in Guangdong province during 2019[J]. Virus Genes,2020,56(5):642-645.
[12] DONG J,RAO D,GENG X,et al.Evolutionary analysis of 3 isolates of Seneca Valley virus from a single pig farm[J]. Canadian Journal of Veterinary Research,2022,86(2):102-107.
[13] 段振华,胡明英,甘一波,等.基于PRRSV灭活疫苗免疫的PRRSV类NADC30株防控案例分析[J].黑龙江畜牧兽医,2021,6:60-66. DUAN Z H,HU M Y,GAN Y B,et al.Case analysis on the prevention and control of PRRSV NADC30-like based on PRRSV inactivated vaccine[J]. Heilongjiang Animal Science and Veterinary Medicine,2021,6:60-66.(in Chinese)
[14] 刘云,朱善元,龚祝南,等.龙胆草及其提取物体外抗猪繁殖与呼吸综合征病毒作用的研究[J].中国畜牧兽医,2019,46(11):3449-3456. LIU Y,ZHU S Y,GONG Z N,et al.Study on the anti-Porcine reproductive and respiratory syndrome virus effect of gentian and its extract[J]. China Animal Husbandry & Veterinary Medicine,2019,46(11):3449-3456.(in Chinese)
[15] 苏雨婷,李兆星,李娟,等.酮酰胺化合物抗病毒活性及其天然产物来源[J].世界中医药,2022,17(8):1171-1179. SU Y T,LI Z X,LI J,et al.Antiviral activities of ketoamide compounds and the natural sources[J]. World Chinese Medicine,2022,17(8):1171-1179.(in Chinese)
[16] 高婷,袁芳艳,刘泽文,等.茶多酚的抗菌抗病毒作用[J].动物医学进展,2022,43(4):107-111. GAO T,YUAN F Y,LIU Z W,et al.Antibacterial and antiviral effects of tea polyphenols[J]. Progress in Veterinary Medicine,2022,43(4):107-111.(in Chinese)
[17] 王钦钦.针对柯萨奇病毒和埃博拉病毒的药物筛选及活性研究[D].合肥:安徽大学,2016. WANG Q Q.Screening and activity study of anti-virus leads against Myocarditis virus and Ebola virus[D].Hefei:Anhui University,2016.(in Chinese)
[18] TAHIR U I,QAMAR M,ALQAHTANI S M,et al.Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants[J]. Journal of Pharmaceutical Analysis,2020,10(4):313-319.
[19] 孙瑜雪,魏霞飞,李杰,等.抑制HBV核心启动子转录活性的化合物筛选与鉴定[J].第三军医大学学报,2021,43(13):1192-1203. SUN Y X,WEI X F,LI J,et al.Screening and identification of compounds inhibiting transcriptional activity of HBV core promoter[J]. Journal of Army Medical University,2021,43(13):1192-1203.(in Chinese)
[20] LINDSAY L,ASHWINI B,IDRIS H,et al.Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other Alphaviruses[J]. Antiviral Research,2018,157:57-67.
[21] 张志,张丽丽,吴发兴,等.猪塞尼卡病毒TaqMan探针荧光RT-PCR方法的建立和应用[J].中国兽医学报,2020,40(1):49-53. ZHANG Z,ZHANG L L,WU F X,et al.Development and application of reverse Real time PCR for Senecavirus A in porcine[J]. Chinese Journal of Veterinary Science,2020,40(1):49-53.(in Chinese)
[22] SANTORO M G,CARAFOLI E.Remdesivir:From Ebola to COVID-19[J]. Biochemical and Biophysical Research Communications,2021,538:145-150.
[23] IMRAN M,KUMAR A M,ASDAQ S M B,et al.Discovery,development,and patent trends on Molnupiravir:A prospective oral treatment for COVID-19[J]. Molecules,2021,26(19):5795.
[24] LIU F,WANG Q,HUANG Y,et al.Rescue of NanoLuc luciferase-expressing Senecavirus A with oncolytic activity[J]. Virus Research,2021,292:198232.
[25] 王小燕.20S-原人参三醇抗柯萨奇B₃病毒作用及机制的初步研究[D].广州:暨南大学,2009. WANG X Y.Study on the antiviral effects and preliminary mechanism of 20S-protopanaxtriol against Coxsackievirus B₃[D].Guangzhou:Jinan University,2009.(in Chinese)
[26] ZHOU Y,LINGLE C J.Paxilline inhibits BK channels by an almost exclusively closed-channel block mechanism[J]. The Journal of General Physiology,2014,144(5):415-440.
[27] WAN Z,LU Y,LIAO Q,et al.Fangchinoline inhibits Human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processing[J]. PLoS One,2012,7(6):e39225.
[28] DONG S,YU R,WANG X,et al.Bis-benzylisoquinoline alkaloids inhibit Porcine epidemic diarrhea virus in vitro and in vivo[J]. Viruses,2022,14(6):1231.
[29] KIM D E,MIN J S,JANG M S,et al.Natural bis-benzylisoquinoline alkaloids-tetrandrine,fangchinoline,and cepharanthine,inhibit Human coronavirus OC43 infection of MRC-5 human lung cells[J]. Biomolecules,2019,9(11):696.
[30] DAS K,ENGLISH D S,FEHR M J,et al.Excited-state processes in polycyclic quinones:The light-induced antiviral agent,hypocrellin,and a comparison with hypericin[J]. The Journal of Physical Chemistry,1996,100(46):18275-18281.
[31] LAW S,LO C,HAN J,et al.Antimicrobial photodynamic therapy with hypocrellin B against SARS-CoV-2 infection?[J]. Photodiagnosis and Photodynamics Therapy,2021,34:102297.

抗A型塞内卡病毒天然产物筛选及颉颃作用机制研究

Screening of the Natural Products Against Senecavirus A and Study on Its Mechanism of Antagonism

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

本文评价

[1]	陈彦希, 王晨, 罗愿, 周远成, 徐志文, 彭远义, 宋振辉, 刘骁. A型塞内卡病毒感染PK-15细胞环状RNA表达谱分析[J]. 中国畜牧兽医, 2023, 50(1): 280-289.
[2]	杜文琪, 夏立叶, 李桂梅, 单虎. A型塞内卡病毒VP1蛋白的原核表达及纯化[J]. 中国畜牧兽医, 2022, 49(7): 2708-2715.
[3]	赵天睿, 邵锦华, 王朝好, 严蕊, 雷镒妃, 刘晓雅, 胡长敏. 犬猫皮肤病细菌性病原分离鉴定及天然产物抑菌效果分析[J]. 中国畜牧兽医, 2022, 49(4): 1556-1567.
[4]	姚娜, 龚静芝, 范益敏, 仰彬, 陶建平, 黄思扬. 弓形虫病治疗药物的研究进展[J]. 中国畜牧兽医, 2020, 47(4): 1250-1257.
[5]	王爱珍, 安立龙. 褐藻岩藻聚糖生物活性的研究进展[J]. , 2013, (5): 97-100.
[6]	王思芦. 动物免疫增强剂的研究进展[J]. , 2013, (5): 195-199.